Skip Navigation

A Multicenter, Open-label, Expanded Access Study of Axicabtagene Ciloleucel for the Treatment of Subjects With Relapsed/Refractory Large B-cell Lymphoma

Brief Summary

Type:
Lymphomas

Study Type:
Treatment

Phase:
N/A

ClinicalTrials.gov Identifier:
NCT03153462

Study #:
STUDY00142214

Start Date:
Oct 24, 2018

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03153462

View Complete Trial Details & Eligibility at ClinicalTrials.gov